Metabolomics biomarkers to predict acamprosate treatment response in alcohol-dependent subjects
Abstract Precision medicine for alcohol use disorder (AUD) allows optimal treatment of the right patient with the right drug at the right time. Here, we generated multivariable models incorporating clinical information and serum metabolite levels to predict acamprosate treatment response. The sample...
Enregistré dans:
Auteurs principaux: | David J. Hinton, Marely Santiago Vázquez, Jennifer R. Geske, Mario J. Hitschfeld, Ada M. C. Ho, Victor M. Karpyak, Joanna M. Biernacka, Doo-Sup Choi |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d17a8ba0a08e49ca9953eacbb578a883 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
New biomarkers of coffee consumption identified by the non-targeted metabolomic profiling of cohort study subjects.
par: Joseph A Rothwell, et autres
Publié: (2014) -
Serum metabolomic biomarkers of perceptual speed in cognitively normal and mildly impaired subjects with fasting state stratification
par: Kamil Borkowski, et autres
Publié: (2021) -
Metabolomic biomarkers in serum and urine in women with preeclampsia.
par: Marie Austdal, et autres
Publié: (2014) -
Plasma metabolomic profiling reveals potential onset of lay biomarkers in broiler breeders
par: Mohammad Afrouziyeh, et autres
Publié: (2022) -
Discovery and validation of an NMR-based metabolomic profile in urine as TB biomarker
par: José Luis Izquierdo-Garcia, et autres
Publié: (2020)